These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 25234819)

  • 1. First report of successful clearance of hepatitis B and D coinfection with tenofovir monotherapy.
    James G; Sidhu P; Raza M
    Hepatology; 2015 Jul; 62(1):317-8. PubMed ID: 25234819
    [No Abstract]   [Full Text] [Related]  

  • 2. Tenofovir for Hepatitis Delta.
    Soriano V; Barreiro P; de Mendoza C
    Hepatology; 2016 Apr; 63(4):1395-6. PubMed ID: 26096808
    [No Abstract]   [Full Text] [Related]  

  • 3. Tenofovir as a first line option for prophylaxis in a patient with hepatitis B virus associated nephrotic syndrome.
    Unverdi S; Ceri M; Köklü S; Unverdi H; Koçak E; Duranay M
    Ann Hepatol; 2011; 10(3):372-3. PubMed ID: 21677344
    [No Abstract]   [Full Text] [Related]  

  • 4. Response to Schmutz et al., 'Combination of tenofovir and lamivudine versus tenofovir after lamivudine failure for therapy of hepatitis B in HIV-coinfection'.
    Matthews GV; Dore GJ
    AIDS; 2007 Mar; 21(6):777-8. PubMed ID: 17413705
    [No Abstract]   [Full Text] [Related]  

  • 5. Incidental treatment of hepatitis B virus infection in an AIDS patient.
    Warner D
    AIDS Read; 2000 Jun; 10(6):376. PubMed ID: 10881369
    [No Abstract]   [Full Text] [Related]  

  • 6. Report from the 2nd International Workshop on HIV and Hepatitis Co-Infection, January 12-14, 2006, Amsterdam, Netherlands. Tenofovir or adefovir for hepatitis B.
    TreatmentUpdate; 2006; 18(2):4. PubMed ID: 17228455
    [No Abstract]   [Full Text] [Related]  

  • 7. Adefovir-lamivudine combination therapy and hepatitis B viral kinetics.
    Mutimer D
    J Hepatol; 2005 Aug; 43(2):200-2. PubMed ID: 15975684
    [No Abstract]   [Full Text] [Related]  

  • 8. Severe vitamin D deficiency in a patient treated for hepatitis B with tenofovir.
    Kumar N; Bower M; Nelson M
    Int J STD AIDS; 2012 Jan; 23(1):59-60. PubMed ID: 22362693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone scintigraphy and secondary osteomalacia due to nephrotoxicity in a chronic hepatitis B patient treated with tenofovir.
    Gómez Martinez MV; Gallardo FG; Pirogova T; García-Samaniego J
    Rev Esp Med Nucl Imagen Mol; 2014; 33(2):103-5. PubMed ID: 23920225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adefovir dipivoxil to prevent exacerbation of lamivudine-resistant hepatitis B infection during chemotherapy for non-Hodgkin's lymphoma.
    Enomoto M; Nishiguchi S; Seki S; Yamane T; Hino M
    Am J Gastroenterol; 2004 Aug; 99(8):1619-20. PubMed ID: 15307884
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of patients with lamivudine-resistant and adefovir dipivoxil-resistant chronic hepatitis B virus infection: is tenofovir the answer?
    Trojan J; Stuermer M; Teuber G; Berger A; Faust D
    Gut; 2007 Mar; 56(3):436-7; author reply 437. PubMed ID: 17339249
    [No Abstract]   [Full Text] [Related]  

  • 12. Letter: First-line monotherapies for chronic hepatitis B - indirect comparison between entecavir and tenofovir.
    Maratea D; Fadda V; Trippoli S; Messori A
    Aliment Pharmacol Ther; 2013 Mar; 37(5):584-5. PubMed ID: 23369168
    [No Abstract]   [Full Text] [Related]  

  • 13. Replacement of tenofovir with adefovir may result in reactivation of hepatitis B virus replication.
    Schildgen O; Hartmann H; Gerlich WH
    Scand J Gastroenterol; 2006 Feb; 41(2):245-6. PubMed ID: 16484132
    [No Abstract]   [Full Text] [Related]  

  • 14. Controversies about the treatment of hepatitis B (lamivudine, interferon, a combination or more?).
    Desai HG; Chowdhury A
    Trop Gastroenterol; 2003; 24(3):157-60. PubMed ID: 14978995
    [No Abstract]   [Full Text] [Related]  

  • 15. Oral tenofovir arm of VOICE trial discontinued early.
    McEnery R
    IAVI Rep; 2011; 15(5):21. PubMed ID: 22121550
    [No Abstract]   [Full Text] [Related]  

  • 16. [Acute renal failure, Fanconi syndrome and insipidus diabetes in a HIV-infected patient treated with Tenofovir].
    Harmouche H; Le Bras P; Bignani O; Delfraissy JF; Goujard C
    Rev Med Interne; 2005 Jun; 26(6):522-3. PubMed ID: 15936484
    [No Abstract]   [Full Text] [Related]  

  • 17. Tenofovir treatment of the severe acute hepatitis B.
    Casals-Seoane F; Arberas-Díez B; García-Buey L
    Rev Esp Enferm Dig; 2013 Jan; 105(1):57-8. PubMed ID: 23548017
    [No Abstract]   [Full Text] [Related]  

  • 18. Improvements in parameters of end-stage liver disease in patients with HIV/HBV-related cirrhosis treated with tenofovir.
    Matthews GV; Cooper DA; Dore GJ
    Antivir Ther; 2007; 12(1):119-22. PubMed ID: 17503756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment with tenofovir in a child C cirrhotic patient with lamivudine-resistant hepatitis B virus awaiting liver transplantation. Post-transplant results.
    Taltavull TC; Chahri N; Verdura B; Gornals J; Lopez C; Casanova A; Cañas C; Figueras J; Casais LA
    Transpl Int; 2005 Jul; 18(7):879-83. PubMed ID: 15948869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized trial of combination hepatitis B therapy in HIV/HBV coinfected antiretroviral naïve individuals in Thailand.
    Matthews GV; Avihingsanon A; Lewin SR; Amin J; Rerknimitr R; Petcharapirat P; Marks P; Sasadeusz J; Cooper DA; Bowden S; Locarnini S; Ruxrungtham K; Dore GJ
    Hepatology; 2008 Oct; 48(4):1062-9. PubMed ID: 18697216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.